The impact of haematocrit levels and erythropoietin treatment on overall and cardiovascular mortality and morbidity - the experience of the Lombardy Dialysis Registry

被引：153

作者：

Locatelli, F ^{[1
]}

Conte, F ^{[1
]}

Marcelli, D ^{[1
]}

机构：

[1] Lombardy Dialysis & Transplant Registry, Milan, Italy

来源：

NEPHROLOGY DIALYSIS TRANSPLANTATION | 1998年 / 13卷 / 07期

关键词：

D O I：

10.1093/ndt/13.7.1642

中图分类号：

R3 [基础医学]; R4 [临床医学];

学科分类号：

1001 ; 1002 ; 100602 ;

摘要：

[No abstract available]

引用

页码：1642 / 1644

页数：3

共 9 条

[1] REVERSAL OF LEFT-VENTRICULAR HYPERTROPHY FOLLOWING RECOMBINANT-HUMAN-ERYTHROPOIETIN TREATMENT OF ANEMIC DIALYZED UREMIC PATIENTS [J].

CANNELLA, G ;

LACANNA, G ;

SANDRINI, M ;

GAGGIOTTI, M ;

NORDIO, G ;

MOVILLI, E ;

MOMBELLONI, S ;

VISIOLI, O ;

MAIORCA, R .

NEPHROLOGY DIALYSIS TRANSPLANTATION, 1991, 6 (01) :31-37

[2] REGRESSION OF LEFT-VENTRICULAR HYPERTROPHY IN HYPERTENSIVE DIALYZED UREMIC PATIENTS ON LONG-TERM ANTIHYPERTENSIVE THERAPY [J].

CANNELLA, G ;

PAOLETTI, E ;

DELFINO, R ;

PELOSO, G ;

MOLINARI, S ;

TRAVERSO, GB .

KIDNEY INTERNATIONAL, 1993, 44 (04) :881-886

[3] Increased risk of cardiovascular disease with erythropoietin in chronic dialysis patients [J].

Evans, SJW .

NEPHRON, 1997, 76 (01) :116-116

[4] Subacute infusion of physiological doses of parathyroid hormone raises blood pressure in humans [J].

Fliser, D ;

Franek, E ;

Fode, P ;

Stefanski, A ;

Schmitt, CP ;

Lyons, M ;

Ritz, E .

NEPHROLOGY DIALYSIS TRANSPLANTATION, 1997, 12 (05) :933-938

[5] The impact of anemia on cardiomyopathy, morbidity, and mortality in end-stage renal disease [J].

Foley, RN ;

Parfrey, PS ;

Harnett, JD ;

Kent, GM ;

Murray, DC ;

Barre, PE .

AMERICAN JOURNAL OF KIDNEY DISEASES, 1996, 28 (01) :53-61

[6] Increased risk of cardiovascular disease with erythropoietin in chronic dialysis patients [J].

Iseki, K ;

Nishime, K ;

Uehara, H ;

Tokuyama, K ;

Toma, S ;

Yoshihara, K ;

Kowatari, T ;

Terukina, S ;

Osawa, A ;

Fukiyama, K .

NEPHRON, 1996, 72 (01) :30-36

[7] Increased risk of cardiovascular disease with erythropoietin in chronic dialysis patients - Reply [J].

Iseki, K .

NEPHRON, 1997, 76 (01) :117-117

[8] 1983 TO 1992 - REPORT ON REGULAR DIALYSIS AND TRANSPLANTATION IN LOMBARDY [J].

LOCATELLI, F ;

MARCELLI, D ;

CONTE, F ;

LIMIDO, A ;

LONATI, F ;

MALBERTI, F ;

SPOTTI, D .

AMERICAN JOURNAL OF KIDNEY DISEASES, 1995, 25 (01) :196-205

[9]

Parfrey PS, 1996, NEPHROL DIAL TRANSPL, V11, P1277

← 1 →